Navigation Links
Diabetes Labeled As World's Fifth Killer Disease

High blood sugar is a definitive indication of diabetes. Researchers from Harvard School of Public Health have conducted a study, which has shown //that diabetes can kill people much before they are even diagnosed with the disease.

Danaei and colleagues analyzed data from 52 nations. Their findings have shown that high blood sugar is the cause of an astounding 3,160,000 deaths each year. 'Our results show that one in five deaths from heart disease and one in eight from stroke worldwide are attributable to higher-than-optimum blood [sugar],' Danaei and colleagues conclude.

The findings which have been published in The Lancet rates high blood sugar among the ranks of other killer causes like smoking, high cholesterol and obesity, and is a major concern in the developing nations, which are highly susceptible to incidence of diabetes.
'"/>




Page: 1

Related medicine news :

1. Is Diabetes the Leading Cause of Kidney Failure in India
2. Diabetes and Depression often go hand-in-hand
3. Thirty minutes of work up per day reduces the risk of Diabetes
4. Diabetes on the rise
5. Irregular Periods Linked to Diabetes
6. Cinnamon combats Diabetes
7. Good News For Women With Gestational Diabetes
8. Processed Meat, Diabetes connection Found
9. Pancreatic Cancer may be linked to Diabetes
10. Gestational Diabetes linked to Chromosomal defici
11. A way to slow the progression of Type 1 Diabetes
Post Your Comments:
Breaking Medicine Technology:Published Data Demonstrate Arena Pharmaceuticals' Lorcaserin Has Low Abuse Potential 2Published Data Demonstrate Arena Pharmaceuticals' Lorcaserin Has Low Abuse Potential 3Published Data Demonstrate Arena Pharmaceuticals' Lorcaserin Has Low Abuse Potential 4ARKRAY, Inc. Receives FDA 510k Clearance on the Assure(R) Platinum Auto-Code Blood Glucose Monitoring System 2FDA Grants Cequent IND - Clears Way for First-Ever Clinical Trial of Orally Delivered RNAi Therapeutic: CEQ508, a tkRNAi Drug Candidate in Oncology 2FDA Grants Cequent IND - Clears Way for First-Ever Clinical Trial of Orally Delivered RNAi Therapeutic: CEQ508, a tkRNAi Drug Candidate in Oncology 3FDA Grants Cequent IND - Clears Way for First-Ever Clinical Trial of Orally Delivered RNAi Therapeutic: CEQ508, a tkRNAi Drug Candidate in Oncology 4 242 million grant aids study of lung cancer in people who never smoked 9305 1 242 million grant aids study of lung cancer in people who never smoked 9305 2 242 million grant aids study of lung cancer in people who never smoked 9305 3Genetic tests advertised directly to the consumer 9302 1Genetic tests advertised directly to the consumer 9302 2Lumenis Worlds Largest Medical Laser Company Honored by Premier Healthcare Alliance for Exceeding Performance Expectations 52297 1Lumenis Worlds Largest Medical Laser Company Honored by Premier Healthcare Alliance for Exceeding Performance Expectations 52297 2Lumenis Worlds Largest Medical Laser Company Honored by Premier Healthcare Alliance for Exceeding Performance Expectations 52297 3Lumenis Worlds Largest Medical Laser Company Honored by Premier Healthcare Alliance for Exceeding Performance Expectations 52297 4